Wed, Oct 22, 2014, 1:18 AM EDT - U.S. Markets open in 8 hrs 12 mins


% | $
Quotes you view appear here for quick access.

MELA Sciences, Inc. Message Board

  • adeiflig adeiflig Mar 25, 2009 4:55 PM Flag

    Buy on August 15th, Dead Money Now...

    It will still take 6 months before any activity on this stock.

    With little to no demand expect MELA to drop in the $ 1.30/share area.

    Why keep dead money here, come back in August 15th.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • I don't consider it dead money when I can accumulate now and cash in at 5 to 10 times value in 9 months! IMO> If I need the money tomorrow, that is different story, but I don't! You are assuming you can do better else where over the upcoming 9 month period, if so - inform us please!! That is why we call it INVESTING!!

      • 1 Reply to kgrichard5
      • These biotech companies all act in the same manner. This is nothing personal, just what I have noticed about most of them.

        Yes, MELA has a great product, but it is still 6 months away from any approval and 9 months from any possible revenue.

        People don't invest anymore for long term.

        To move the stock you need a catalyst. Unfortunately there will be none until August 15th. So, with no catalyst and plenty of sellers, expect a steady drop to the $ 1.30/share area.

        Yes, you can load up, but why do it now when you can buy 4 times the quantity in a few months.

        Your best bet is to buy 30 to 45 days before FDA is to vote on the device.

        Let is soar and then you sell after 3 days.

        So, buy at $ 1.30/share, sell at $ 13/share and make a nice 1000% return in 45 days.

    • $1.30 is a ridiculous price target. If you want to stay away until August 15, by all means do so. Some of us prefer to accumulate.

2.15+0.30(+16.22%)Oct 21 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.